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ABSTRACT
Introduction Grief is an emotional reaction to the loss 
of a loved one with a natural recovery. Approximately 
10% of people who lose a loved one develop prolonged 
grief disorder (PGD). Internet- based and computer- based 
interventions (ie, internet- delivered cognitive–behavioural 
therapy, iCBT) are a cost- effective alternative that makes it 
possible to reach more people with PGD. The main aim of 
this study is to assess the feasibility of a new iCBT—called 
GROw—for PGD. As a secondary objective, the potential 
effectiveness of GROw will be explored.
Methods and analysis This study is a two- arm feasibility 
randomised trial. A total of 48 adults with PGD who 
meet the eligibility criteria will be randomised to the 
experimental group (iCBT: GROw) or the active control 
group (face- to- face CBT treatment). The treatment is 
organised sequentially in eight modules in the iCBT 
format and 8–10 sessions in the face- to- face format, and 
both formats have the same therapeutic components. 
There will be five assessment points with qualitative and 
quantitative evaluations: screening, baseline, after the 
intervention, 3- month follow- up and 12- month follow- up. 
Consistent with the objectives, the measures are related 
to the feasibility outcomes for the main aim of the study 
(participant adherence, expectations and satisfaction 
with the treatment, preferences, alliance and utility) and 
psychological and mental health outcomes for secondary 
analyses (symptoms of grief, symptoms of depression, 
symptoms of anxiety, affectivity, quality of life, work and 
social adaptation, post- traumatic growth, purpose in life, 
mindfulness and compassion).
Ethics and dissemination The Ethics Committee 
of the Universitat Jaume I (Castellón, Spain) granted 
approval for the study (CD/002/2019). Dissemination will 
include publications and presentations at national and 
international conferences.
Trial registration number NCT04462146.
INTRODUCTION
Grief is an emotional reaction to the loss of a 
loved one with gradual recovery. During the 
recovery process, intense feelings of regret and 
longing are considered natural and usually 
diminish over time.1 Unfortunately, 9.8% of 
the adult non- psychiatric population who 
suffer a loss develop prolonged grief disorder 
(PGD).2 PGD is described by the Interna-
tional Statistical Classification of Diseases 
and Related Health Problems3 as a persistent 
and pervasive grief response characterised by 
longing for the deceased or persistent preoc-
cupation with the deceased, accompanied by 
intense emotional pain. In addition, at least 
6 months must have elapsed since the death 
of the loved one to make this diagnosis. 
Chronically disabling and distressing grieving 
symptoms are also formally recognised in 
the Diagnostic and Statistical Manual of 
Mental Disorders, Fifth Edition (DSM-54) as 
persistent complex bereavement disorder 
(PCBD) within the category of conditions for 
further study. PCBD is defined as a severe and 
persistent grief and mourning reaction.4 The 
mourning period is not only associated with 
the risk of developing PGD or PCBD, but it 
is also associated with the development of 
Strengths and limitations of this study
 ► Participants will be randomly assigned to the ex-
perimental group (internet- delivered cognitive–be-
havioural therapy (iCBT)) or active control group 
(face- to- face treatment).
 ► Both short- term and long- term follow- up periods (3 
and 12 months) are planned.
 ► Due to the pandemic situation produced by 
COVID-19, adaptations in the treatment format in 
the face- to- face control condition could be made.
 ► Potential effectiveness of iCBT will be assessed by 
applying within- group changes, and comparisons 
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multiple psychological disorders and other physical and 
psychological symptoms (eg, panic disorder, physical 
health problems, sleep disturbances, increased use of 
medications, increased social and work interference).5–8
In the past decade, several studies have tested different 
interventions for grief symptoms and PGD: cognitive–
behavioural therapies (CBTs),9–16 expressive writing ther-
apies,17–19 group interventions (eg, see works20–22) and 
mindfulness and compassion- based interventions.23 24 
Results from a recent meta- analysis show that psycholog-
ical interventions are effective for reducing grief symp-
toms in bereaved adults.25
However, most people in need of treatment do not 
receive any services.26 The existence of effective psycho-
logical treatments does not ensure that these treatments 
reach the people who need them.27 Different ways of 
administering treatments are needed to improve their 
dissemination and reach a larger number of under-
served people.26 27 Less than 50% of the people who 
need treatment receive it, even in high- income coun-
tries.28 Therefore, internet- based and computer- based 
interventions are becoming increasingly popular. These 
interventions involve greater access to care and less 
stigma, compared with visiting mental health clinics.29 30 
They are cost- effective and often cheaper than face- to- 
face interventions.31 Meta- analytic evidence has shown 
that internet- based interventions are effective, showing 
evidence of greater effects compared with control groups, 
and they are as effective as face- to- face psychotherapy 
(eg, see previous works30 32–36). Particularly, internet- 
delivered cognitive–behavioural therapy (iCBTs) belongs 
to the internet- based and computer- based intervention 
category. In iCBTs, patients log into a secure website to 
access, read and download online materials organised in 
a series of lessons or modules.37 iCBTs are the most widely 
researched treatment models provided by the internet,38 
and more than 200 randomised controlled trials (RCTs) 
have been published about them.34 iCBTs have been 
shown to be clinically effective compared with controls,39 
and they have a lower rate of negative symptom results 
than control conditions.40
In addition, COVID-19 has made PGD a major public 
health concern worldwide.41 The pandemic has produced 
widespread implementation of social distancing and 
visitor restrictions in healthcare centres, thus compli-
cating grief problems.42 43 Recent evidence has pointed 
out that mental and physical health problems can emerge 
if the needs of people who experience the loss of a loved 
one are not addressed.44 To our knowledge, evidence- 
based treatments delivered through internet for PGD are 
not widely available. Therefore, it is vital to promote the 
development and dissemination of internet- based PGD 
treatments,41 and telecommunication- based alternatives 
are proposed as important components for supporting 
bereaved people.43
To date, there are several internet- based and computer- 
based interventions for the treatment and prevention of 
grief symptoms and PGD (eg, see previous works45–47), 
with promising results in reducing symptoms associated 
with grief.48 These studies have used treatment through 
email45 47 49 or an online platform.46 50–52 Despite this, few 
studies have tested iCBT for PGD. There are some studies 
on the feasibility, acceptance and usability of traditional 
face- to- face treatments (eg, see previous works53–56), but 
almost none focus on internet- based and computer- 
based interventions. Related to this, we found the study 
by Schladitz et al,57 which evaluates the user acceptance 
of an internet- based self- help programme for grief and 
loss in elderly people, showing high user acceptance of 
the programme. As far as we know, none of these studies, 
whether feasibility studies or RCTs, has been tested in 
the Spanish population. For these reasons, an iCBT for 
PGD—called GROw—was originally developed for the 
Spanish- speaking population.
Objectives
The main aim of this study is to investigate the feasibility 
of an iCBT for people with PGD—GROw—compared 
with a face- to- face intervention for PGD. Specifically, the 
objectives are (1) to explore patients views of GROw as a 
treatment for PGD; (2) to evaluate the expectations and 
preferences of the treatment in both formats, GROw and 
face- to- face; (3) to investigate patients’ views of the mate-
rials and the study design; (4) to assess the satisfaction 
and acceptability of the treatment; (5) to assess if we can 
recruit the target population; (6) to explore whether the 
assessment is too burdensome; (7) to estimate the rate 
of recruitment and retention to inform the large- scale 
RCT. Additionally, as a secondary objective the potential 
effectiveness of GROw will be explored, this is defined as 
the intragroup changes of symptoms related to PGD from 
baseline to post- test and follow- ups, and with baseline–
post- test being the main comparison.
METHOD
Study design and procedure
This study is a two- arm randomised trial testing the 
feasibility of an iCBT for PGD. The diagnosis of PGD 
will be based on an interview following the criteria of 
the ICD-1158 and a score >25 on the 19- item inventory 
of CG (ICG).59 60 Participants who meet the eligibility 
criteria will be randomly assigned to one of two groups: 
(1) experimental group (iCBT: GROw); and (2) active 
control group (face- to- face treatment applied by a ther-
apist). The waiting list control group has already been 
used in several studies of internet interventions for PGD 
(eg, see previous works46 47 52). For this reason, and to 
increase the quality of this study, and based on feasibility 
questions to design future large studies, an active control 
group will be used. The informed consent form will be 
signed before randomisation. Five assessment points will 
be included: diagnosis and inclusion/exclusion criteria 
(screening), baseline (t1), immediately after the interven-
tion (t2), 3- month follow- up (t3) and 12- month follow- up 
(t4). In order to promote participant retention in the 
 on N
ovem











pen: first published as 10.1136/bm




3Tur C, et al. BMJ Open 2021;11:e046477. doi:10.1136/bmjopen-2020-046477
Open access
treatment and complete follow- up periods, reminders 
emails will be sent during treatment (eg, to enter the 
web platform or attend the face- to- face session) and 
follow- ups. The study was registered in the  clinicaltrials. 
gov database (NCT04462146, 8 July 2020) and will be 
conducted following the extension of the Consolidated 
Standards of Reporting Trials (CONSORT) statement for 
pilot and feasibility studies,61 the Consolidated Standards 
of Reporting Trials of Electronic and Mobile Health 
Applications and online TeleHealth guidelines,62 and the 
Standard Protocol Items: Recommendations for Inter-
ventional Trials (SPIRIT) guidelines.63 64
Participants
Eligibility criteria
To participate in the study, participants will meet the 
following inclusion criteria: (1) age ≥18 years; (2) 
having a total score of >25 on the 19- item inventory of 
CG (ICG)59 60 and meeting diagnostic criteria for PGD 
according to the ICD-11; (3) ability to understand and 
read Spanish; (4) ability to use a computer and having 
access to the internet; (5) having an email address; and 
(6) signing an informed consent. Exclusion criteria are as 
follows: (1) presence of risk of suicide or self- destructive 
behaviours; (2) presence of another severe mental 
disorder (ie, substance abuse or dependence, psychotic 
disorder, dementia or bipolar disorder); (3) presence of 
severe personality disorder (eg, borderline personality 
disorder, obsessive- compulsive personality disorder); (4) 
presence of a medical condition whose severity or charac-
teristics prevent participation in treatment; (5) receiving 
another psychological treatment during the study; (6) 
an increase and/or change in the medication during the 
study period. The medication is evaluated at baseline (t1), 
after the intervention (t2), at 3- month follow- up (t3) and 
at 12- month follow- up (t4). Any increase and/or change 
in the medication during the study period will imply the 
participant’s exclusion from subsequent analyses.
Sample size
Based on an estimated number of dropouts of 30%65–67 
and considering that the secondary objective is to explore 
the potential effectiveness defined as the pretest–post- test 
improvement of symptoms related to PGD, a minimum 
of 48 participants (24 per group) will be sufficient for 
the within- group t- test to detect a medium effect size 
(Cohen’s d=0.50)68 with a power of 0.80 and an alpha 
of 0.05. The effect size was defined as the pretest–post- 
test mean change divided by the SD of change scores. 
In a review of 50 meta- analyses on the effectiveness of 
psychological interventions,69 integrated their average 
effect sizes, finding a median value of d=0.75. In place 
of using this estimate to determine the sample size, and 
with the purpose of obtaining a more demanding sample 
size, Cohen’s recommendation for a medium effect size 
of d=0.50 was assumed. G*Power V.3 software was used to 
perform power analysis calculations.70
Recruitment and screening
Recruitment will be conducted using professional social 
networks (ie, Linkedin) and non- professional social 
networks (eg, Facebook and Instagram). The study will 
be announced on the Universitat Jaume I website and 
other media (eg, local newspapers and radio). Posters will 
be placed in different nearby places (Universitat Jaume I 
and Universitat de València). In addition, patients who 
attend the Emotional Disorders Clinic at Universitat 
Jaume I may be recruited.
People interested in the study may request participation 
via email or telephone directed to the specific account/
number associated with the project, and an experienced 
therapist will conduct a telephone assessment to deter-
mine whether the inclusion and exclusion criteria are 
met. During this call, interested participants will also be 
informed of the study conditions (duration, specific char-
acteristics, etc). After accepting the terms and signing the 
informed consent, the participants will be randomised, 
using EPIDAT V.4.2, to the experimental group or active 
control group by an independent researcher. Participants 
will be informed of the assigned treatment by phone call. 
All of them will complete the same evaluation (screening, 
t1, t2, t3 and t4) through a specific online platform 
(https:// psic olog iayt ecno logia. labpsitec. es/) and phone 
call interviews. Participants will access the study volun-




Both groups will receive the same therapeutic content, 
but applied in different formats. The treatment is organ-
ised sequentially in eight modules in the online format 
and 8–10 sessions in the face- to- face format (see table 1). 
The main therapeutic components are as follows: motiva-
tion for change, psychoeducation, behavioural activation, 
exposure, mindfulness and compassion strategies, inte-
gration and restoration of loss, cognitive reappraisal and 
relapse prevention. This is an adapted version of the orig-
inal intervention protocol for complicated grief developed 
by Botella et al.71 This protocol was based on Neimeyer’s 
programme, which fosters meaning reconstruction in 
complicated grief (CG)72 73 and includes elements of the 
Foa and Rothbaum74 programme for treating trauma- 
like symptoms and Linehan’s75 guidelines for mindful-
ness strategies. In updating this treatment, elements of 
the intervention developed by Shear,76 which has shown 
efficacy in different controlled studies,14–16 have been 
included. This intervention is based on the dual- process 
model of coping with bereavement,77 which identifies two 
types of stressors, loss- oriented and restoration- oriented, 
and proposes that adaptive coping is composed of 
confrontation- avoidance of loss and restoration stressors. 
Specific elements (ie, cognitive reappraisal) of other 
computerised psychological treatments for grief have 
also been included (eg, see previous works47 76 78). Lastly, 
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the treatment contains new mindfulness activities and 
compassion and self- compassion strategies.79–84
iCBT for PGD (GROw)
This individual self- applied programme is accessible 
online via https:// psic olog iayt ecno logia. labpsitec. es, a 
website designed by Labpsitec (Laboratory of Psychology 
and Technology, Universitat Jaume I, and Universitat de 
València). Participants will receive a username and pass-
word sent to their email address, and they will have access 
to one 60- minute module per week, although modules 
4–6 may take 2 weeks due to their difficulty. The treat-
ment will last 8–10 weeks. The programme contains 
texts, videos, photos, diagrams, interactive exercises, and 
downloadable pdfs and audios (see figure 1). Participants 
can also log in at any time to review content, see the 
calendar where the session record appears and view their 
progress through visual graphs (ie, measures of grief, 
anxiety, depression, and positive and negative affect). A 
weekly support call from a trained clinician will be made 
(maximum 10 min) in order to (1) review and reinforce 
participants’ effort and achievements, (2) motivate them 
to continue to work on the programme content, and 
(3) clarify any doubts about the use and functioning of 
GROw. Patients will receive up to 10 phone calls over a 
period of 8–10 weeks, and so they will have a maximum 
of 100 min of therapeutic support. No additional clinical 
content will be released during the phone calls.
Individual face-to-face treatment for PGD
This treatment will be carried out face- to- face by a trained 
clinician with a master’s degree in clinical psychology and 
specific training in the treatment of grief. The partici-
pant will receive materials about meditation audios and 
annexes with records and templates to complete the 
exercises. The sessions will take place at the Emotional 
Disorders Clinic at Universitat Jaume I in Castellón and 
Valencia (Spain) or in nearby centres and associations 
(eg, Valencia or Alicante). Each session will last approx-
imately 60 min. There will be weekly individual sessions, 
and the content from 4 to 6 sessions could require 2 weeks 
Table 1 Specific objectives and therapeutic contents of the intervention
Module/Session Objective Content
1. Welcome module: Starting the 
programme
Present the treatment
Increase motivation and adherence
Introduce strategy to manage stress and 
anxiety
General explanation of treatment
Presentation of grief cases as an example
Motivation for change
Slow breathing technique
2. Understanding reactions to loss Information about the grieving process 
and PGD
Increase adaptive activities
Become aware of grief
Psychoeducation
Behavioural activation
Grief self- monitoring diary
3. Coping with loss Recognise and accept emotional 
experiences




4. Loss integration and restoration: 
First steps
Integration and restoration of loss by 
writing
Giving a metaphorical meaning to loss
Loss diary: Chapter 1, life before loss
5. Deepening integration and 
restoration of loss
Integration and restoration of loss by 
writing
Contemplating the death from a different 
perspective
Develop a realistic and complete picture 
of the deceased
Loss diary: Chapter 2, reaction to the death
Cognitive reappraisal
Questions about positive and negative 
aspects and memories of the deceased
6. Consolidating loss integration and 
restoration
Integration and restoration of loss by 
writing
Loss diary: Chapter 3, life after loss
Imaginary conversations with the deceased
7. Self- care, guilt and forgiveness in 
the grieving process
Working on compassion in grief
Working on the emotion of guilt
Working on forgiveness
Psychoeducation about compassion
The compassionate gesture and phrases
Compassionate coping with difficulties
Psychoeducation and strategies about guilt
Psychoeducation and exercise for 
forgiveness (optional)




Reflect on the coping process
Review of the therapeutic achievements
Action plan for high- risk situations
Action plan to face difficult dates
Letter of projection towards the future
PGD, prolonged grief disorder.
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due to its difficulty. The treatment lasts up to 8–10 weeks. 
No weekly support call will be provided.
Outcome measures
A clinical team of mental health professionals with exten-
sive experience in diagnosing and treating stress- related 
disorders will oversee all the cases. Some questionnaires 
will be self- administered online through the virtual plat-
form used in the intervention (https:// psic olog iayt ecno 
logia. labpsitec. es), and other questionnaires/interviews 
will be administered by phone. Participants in both 
groups (GROw and face- to- face) will have the same eval-
uation format. Participants and researchers will receive 
email reminders of each assessment. Table 2 provides 
an overview of the measurements used, each timepoint, 
administration type and group.
Demographics, screening and diagnostic measures
Demographics will include age, sex, educational level, 
occupation, civil status, place of residence and influence 
of situations stemming from the health crisis caused by 
COVID-19 (confinements, care situations, nearby infec-
tions, related deaths, etc), if applicable.
A semistructured interview developed for this study will 
be used to assess some inclusion/exclusion criteria (eg, 
internet access, email, etc).
For the diagnosis, two specific PGD assessment instru-
ments will be used: The Inventory of Complicated Grief 
(IGC), which rates current feelings of grief and differenti-
ates between normal and pathological grief. A total score 
of >25 is needed because this score indicates complicated 
grief.59 60 The Structured Clinical Interview for Compli-
cated Grief (SCI- CG)85 evaluates symptoms of prolonged 
grief in people who lost a loved one 6 months ago or 
more, and it has been adapted specifically for this study by 
translating it into the Spanish language following a back- 
translation procedure. The clinical team may consider 
using the Structured Clinical Interview for DSM- IV (SCID- 
I)86 in some cases in order to make the differential diag-
nosis and ensure that the inclusion/exclusion criteria are 
met. At the end of the interview, the clinician will assess 
the level of distress- interference in functioning (from 0 
‘Absent’ to 8 ‘Very severely disturbing/disabling’) using 
the ADIS (Anxiety Disorders Interview Schedule) clini-
cian’s severity rating scale.87 A clinical team of mental 
health professionals with extensive experience in diag-
nosing and treating stress- related disorders will oversee 
all cases.
Primary outcomes: measures of feasibility
Participant adherence (ie, attrition and dropout percent-
ages) will be assessed in both groups. Moreover, the 
number of sessions/modules completed will be counted. 
In addition, the iCBT format (GROw) will record how 
many times participants enter the modules, how much 
time they spend on each one and whether they review the 
content of the modules.
Participants’ acceptance will be assessed with Expecta-
tions and Satisfaction Questionnaires adapted from Bork-
ovec and Nau,88 usability with the Usability and Acceptance 
Questionnaire89 90 and alliance with the Working Alliance 
Inventory (WAI), adapted from Horvath and Greenberg91 
for online self- administered treatments.
Finally, a semistructured opinion interview with quanti-
tative and qualitative questions was specifically developed 
Figure 1 'Screenshot’ of the ‘Psicología y Tecnología’ (Psychology and Technology) web platform.
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Table 2 Measures, time of assessment, source of measurement and group
Measures Assessment point Assessment source Group
Sociodemographic data Screening Phone interview GROw
Face- to- face
Semistructured interview about inclusion/
exclusion criteria
Screening Phone interview GROw
Face- to- face
SCI- GC Screening, t2, t3, t4 Phone interview GROw
Face- to- face
SCID- I Screening Web GROw
Face- to- face
ADIS clinician’s severity rating scale screening, t2, t3, t4 Web GROw
Face- to- face
ICG Screening, t1, t2, t3, t4 Web GROw
Face- to- face
BDI- II t1, t2, t3, t4 Web GROw
Face- to- face
TBQ t1, t2, t3, t4 Web GROw
Face- to- face
OASIS t1, POSTm/s, t2, t3, t4 Web GROw
Face- to- face
ODSIS t1, POSTm/s, t2, t3, t4 Web GROw
Face- to- face
PANAS t1, POSTm/s, t2, t3, t4 Web GROw
Face- to- face
QLI t1, t2, t3, t4 Web GROw
Face- to- face
WSAS t1, t2, t3, t4 Web GROw
Face- to- face
PTGI t1, t2, t3, t4 Web GROw
Face- to- face
PIL-10 t1, t2, t3, t4 Web GROw
Face- to- face
FFMQ-15 t1, t2, t3, t4 Web GROw
Face- to- face
SCS- SF t1, t2, t3, t4 Web GROw
Face- to- face
Expectations and Satisfaction Questionnaires t1, t2 Phone interview GROw
Face- to- face
Usability and Acceptance Questionnaire t2 Web GROw
WAI t2 Web GROw
Semistructured opinion interview       
 ► Preferences t1, t2 Phone interview GROw
Face- to- face
 ► Usefulness of content t1, t2 Phone interview GROw
Face- to- face
 ► Usefulness of each element of the web t2 Phone interview GROw
ADIS, Anxiety Disorders Interview Schedule; BDI- II, Beck Depression Inventory—Second Edition; FFMQ-15, Five- Facet Mindfulness 
Questionnaire; GROw, Grief- Online, internet- based self- applied treatment for PGD; ICG, Inventory of Complicated Grief; OASIS, Overall 
Anxiety Severity and Impairment Scale; ODSIS, Overall Depression Severity and Impairment Scale; PANAS, Positive and Negative Affect 
Schedule; PIL-10, Purpose- In- Life Test; POSTm/s, post module/session; PTGI, Post- traumatic Growth Inventory; QLI, Quality of Life Index; 
SCID- I, Structured Clinical Interview for DSM- IV; SCI- GC, Structured Clinical Interview for Complicated Grief; SCS- SF, Self- Compassion 















pen: first published as 10.1136/bm




7Tur C, et al. BMJ Open 2021;11:e046477. doi:10.1136/bmjopen-2020-046477
Open access
for this study. It includes (1) a 5- point questionnaire that 
assesses treatment preferences (GROW vs face- to- face) 
and opinions about which treatment is the most useful, 
logical, aversive and recommended; (2) a list of 14 points 
(eg, motivation to change, mindfulness, exposure) about 
the usefulness of each content (assessed from 0; not at all 
useful to 10; maximum usefulness); (3) a list of 4 points 
(text, video, audio and images) about the usefulness of 
each part of the iCBT format (from 0; not useful at all to 
10; maximum usefulness); (4) three semistructured ques-
tions on satisfaction, usefulness and adherence on a scale 
from 0 (not at all) to 10 (very much), with an open ques-
tion about the reason for the score; (5) an open question 
about adverse or unexpected effects in the iCBT group; 
(6) an open question about adverse or unexpected effects 
due to the health crisis produced by COVID-19; and (7) 
two semistructured questions about the acceptance of the 
evaluation procedure and the materials used (from 0; not 
burdensome at all to 10; extremely burdensome).
Psychological and mental health outcomes
Grief symptoms will be assessed using the Inventory of 
Complicated Grief (ICG),59 92 and depression symptoms will 
be assessed using the Beck Depression Inventory—Second 
Edition (BDI- II).93 94 To assess the maladaptive thinking 
common in people with complicated grief, the Typical 
Beliefs Questionnaire (TBQ)95 will be used. The Overall 
Anxiety Severity and Impairment Scale (OASIS)96 97 and the 
Overall Depression Severity and Impairment Scale (ODSIS)98 99 
will be used to assess the frequency and severity of anxiety 
and depression, respectively. Two independent dimen-
sions of affectivity (PA: positive affect; NA: negative 
affect) will be assessed using the Positive and Negative Affect 
Schedule (PANAS).100 101 To assess health- rated quality of 
life, the Quality of Life Index (QLI)102 will be used. The Work 
and Social Adjustment Scale (WSAS)103 104 will be used to 
assess psychosocial functional impairment. Post- trauma 
growth and self- improvement will be assessed using the 
Posttraumatic Growth Inventory (PTGI).105 106 The Purpose- 
In- Life Test (PIL- 10)107 will be used to assess the personal 
experience of meaning in life. The Five- Facet Mindfulness 
Questionnaire (FFMQ-15)108 and the Self- Compassion Scale- 
Short Form (SCS- SF)109 110 will be used to assess the ability 
to be aware in experiencing the moment and the capacity 
for self- compassion, respectively.
Statistical analysis plan
As the main aim of this study is related to the feasibility, 
the main data will be reported narratively illustrated with 
descriptive statistics using the CONSORT 2010 statement61 
to guide for reporting this information. Attrition and 
dropout rates will be calculated using the missing data. 
In the experimental group, the number of times each 
patient uses the programme will be used as the measure 
of adherence. In the active control group, the number 
of times each patient attends a face- to- face treatment 
session will be used as the measure of adherence. The 
summary of the data will be presented as a mean (DS) or 
frequency (%). As a secondary objective, potential effec-
tiveness of iCBT will be assessed by applying within- group 
t- tests between the baseline and post- test and follow- ups. 
In addition, effect sizes and their respective 95% CI 
for intragroup changes will be reported. Comparisons 
between iCBT and face- to- face CBT will not be accom-
plished. These statistical analyses will be conducted for 
completers and intent- to- treat data. Statistical analyses 
will be accomplished with the program SPSS V.25.0.
Patient and public involvement statement
There was no involvement in the design and development 
of the study by patients or the public. The results will be 
communicated to the patients involved through an end- 
of- study report by email. The public will participate in the 
dissemination of the research.
ETHICS AND DISSEMINATION
The protocol for this study was approved by the Ethical 
Committee of the Universitat Jaume I (Castellón, Spain) (06 
March 2019) (file number CD/002/2019). The informed 
consent of each participant will be explained and required in 
the initial phone call. Before giving their informed consent, 
the researchers will inform participants about the study and 
the possibility of leaving at any stage. Written consent will 
be obtained before starting the intervention. The study 
will be conducted in compliance with the Declaration of 
Helsinki and good clinical practice and current EU and 
Spanish legislation on privacy and data protection (Spanish 
Organic Law 3/2018 of 5 December on the Protection of 
Personal Data and Guarantee of Digital Rights). Most of the 
questionnaires will be administered from the web https://
psicologiaytecnologialabpsiteces. Each participant will have 
a unique username- password combination to access the 
site. All data will be protected according to AES (Advanced 
Encryption Standard) polynomial m (x)=×8+×4+×3+×+1 and 
stored on secure servers at the Universitat Jaume I sepa-
rately from personal information, using codes. To protect 
the participants’ privacy, all participant identification infor-
mation will be replaced by a randomly assigned code. An 
isolated list will link the numerical codes with the names of 
the participants. This list and the information obtained from 
the phone calls will be stored in a locked file cabinet located 
inside a room with an electronic lock that records access 
(person, day and time). Only researchers directly involved 
in the current study will have access to these data. Dissemi-
nation will include publications in open access journals with 
impact factor indexed in Journal Citation Reports (JCR) and 
presentations at national and international conferences. An 
end- of- study report of the results of this study will be devel-
oped and sent to all participants by mail.
DISCUSSION
The main aim of this study is to investigate the feasibility 
of an iCBT for people with PGD—GROw—compared with 
a face- to- face intervention for PGD. Specifically, we want 
to investigate the opinion of the participants about the 
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treatment, the study design, the materials used and the 
evaluation process, and also to assess dropout rates and 
evaluate if we can recruit the target population to carry 
out a large- scale RCT in the future. In contrast to other 
psychological disorders, few studies have evaluated the 
acceptability and feasibility of this type of treatment and 
there are few studies focused on the efficacy of internet- 
based and computer- based interventions for PGD (eg, 
see previous works45–47), and almost none of them have 
focused on iCBT.46 50–52
The current situation, due to the COVID-19 pandemic, 
has made PGD a major public health problem world-
wide.41 Increased PGD rates are expected41 due to 
different factors, such as (1) the inability to perform 
proper grief rituals that can have significant posi-
tive outcomes for people experiencing a loss (such as 
attending a funeral)111; (2) the possible feeling that the 
loved one’s death was distressing and not peaceful112; 
(3) widespread implementation of social distancing and 
visitor restrictions in health centres42 43; and (4) the fact 
that disasters with many victims produce higher levels of 
grief symptoms.41
Therefore, psychological treatments for PGD are neces-
sary, but the existence of these treatments does not ensure 
that they reach the people who need them.27 The current 
situation states a new challenge, the restrictions in terms 
of mobility, access to the traditional healthcare system is 
at least more difficult than usual, given the overburden 
of the system due to the pandemic situation, and the 
potential increased risk of exposure for attending to the 
healthcare system. Moreover, the challenges that society 
will face concerning the pandemic in the near future is 
at least unknown, but not very promising. Therefore, 
internet interventions could be a potential solution to 
overcome the current situation and to reach more people 
in need. In addition to that, it is well stated that internet 
provides greater access to care, less stigma compared 
with visiting mental health clinics, and the ability to avoid 
specific obstacles to diagnosis or treatment, such as when 
social anxiety keeps the patient from leaving home.29 In 
addition, there is no need for a therapy room, a lesson/
module can be repeated,113 and they are cost- effective114 
and often cheaper than face- to- face interventions.31
As far as we know, GROw is the first iCBT for PGD 
created in the Spanish language, and it could reach many 
Spanish- speaking countries as a psychological treatment 
to care for people with PGD, who represent about 10% 
of people who have suffered a loss of a loved one2 and is 
becoming a major public health concern worldwide due 
to the COVID-19.41
GROw has been developed based on larger and more 
recent studies on the treatment of PGD (eg, see previous 
works15 16 47). It includes both evidence- based traditional 
therapeutic components for PGD and more innovative 
ones, such as mindfulness and compassion strategies. 
In addition, delivery will be guided, including a weekly 
phone call from a trained therapist, which has been 
shown to be more effective than unguided iCBTs.115 116 
We expect that iCBT—GROw—will be feasible in order to 
carry out a large- scale RCT to determine the efficacy and 
effectiveness of GROw as a treatment for adult patients 
with PGD.
Trial limitations
First, due to the pandemic situation caused by COVID-19 
and related to the mobility restrictions, it is possible that 
the participants assigned to the face- to- face group will not 
be able to attend the sessions in person. For this reason, 
changes and adaptations could be made in the control 
group treatment application format (eg, conduct video-
conferencing sessions). These adaptations would be taken 
into consideration for the future large- scale RCT. Second, 
high dropout rates are expected (30%) according to the 
literature.65–67 For this reason, dropout rates have been 
taken into account in the sample size considerations. 
Finally, for the secondary aim of this feasibility randomised 
trial, conclusions will be limited to exploring its potential 
effectiveness in terms of intragroup changes (changes 
from baseline to post- intervention and follow- ups), with 
baseline–post- test being the main comparison, without 
considering between- group comparisons.
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